Home › Aortic Valve Stenosis › NCT07008911
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
CardioHeartConnect: Commercially Available Fitness mHealth for Cardiac Rehabilitation Among Individuals Recovering From Transcatheter Aortic Valve Replacement
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Appropriate for cardiac rehabilitation (CR) referral, as determined by the UCHealth Structural Heart \& Valve Clinic team * Community-dwelling * Reside in the United States * Able to speak and understand English * Able to provide informed consent * Able to stand with or without an assistive device * Able to see and hear content on the Peloton App via phone, tablet, or computer Exclusion Criteria: \- Determined to be inappropriate for cardiac rehabilitation referral by the UCHealth Structural Heart and Valve Clinic team
About the study
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
What is being tested
- CardioHeartConnect (behavioral)
- CardioHeartEd (behavioral)
Sponsor: University of Colorado, Denver · Participants: 200 · Started: Aug 29, 2025
Contact the study team
- Joshua Rosen · Phone: 303-724-1889
- Madeline Balser, MPH, MSW · Phone: 303-724-1883
Official record on ClinicalTrials.gov — NCT07008911
Locations in the U.S.
| Colorado | UCHealth Structural Heart and Valve Clinic, Aurora |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.